The Journal of Organic Chemistry
Page 26 of 33
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
2
-(9
H
-[3,9'-Bicarbazol]-9-yl)-10-(tert-butyl)bis(benzofuro)[2,3-b:3',2'-e]pyridine (4bb).
Purified by column chromatography (eluent nꢀhex/AcOEt 10:1) on silica gel followed by GPC
1
(
CHCl
3
). 175.7 mg, 55%, white solid; m.p. 257.2–258.9 °C; H NMR (400 MHz, CDCl
3
) δ 1.46 (s,
9H), 7.30–7.39 (m, 3H), 7.44 (d, J = 3.6 Hz, 4H), 7.50–7.52 (m, 2H), 7.57–7.64 (m, 4H), 7.77 (dd, J
8.6, 2.1 Hz, 1H), 7.93 (d, J = 8.6 Hz, 1H), 8.03 (s, 1H), 8.16–8.21 (m, 3H), 8.28 (d, J = 1.8 Hz,
=
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
13
1H), 8.34 (d, J = 1.5 Hz, 1H), 8.86 (s, 1H); C NMR (100 MHz, CDCl
3
) δ 31.9, 35.1, 109.9, 110.1,
1
1
1
6
10.8, 111.7, 112.6, 113.8, 114.4, 117.2, 119.6, 119.72, 119.78, 120.4, 120.6, 120.8, 122.1, 122.8,
23.0, 123.2, 124.5, 124.6, 125.77, 125.79, 126.0, 126.7, 126.9, 130.1, 131.0, 133.2, 140.5, 141.9,
+
42.1, 147.2, 153.1, 153.6, 162.0, 162.4; HRMS (APCI) m/z (M+H) calcd for C45
H
32
3
N O
2
:
46.2489, found: 646.2492.
2-(tert-Butyl)-10-(3,6-di-tert-butyl-9H-carbazol-9-yl)bis(benzofuro)[2,3-b:3',2'-e]pyrid
ine (4bc). Purified by column chromatography (eluent nꢀhex/AcOEt 10:1) on silica gel followed by
1
GPC (CHCl
3
). 265.7 mg, 89%, white solid; m.p. 210.2–212.2 °C; H NMR (400 MHz, CDCl
3
) δ
1
.44 (s, 9H), 1.49 (s, 18H), 7.36 (dd, J = 8.6, 0.5 Hz, 2H), 7.49 (dd, J = 8.6, 2.0 Hz, 2H), 7.60–7.60
(m, 2H), 7.68 (dd, J = 8.7, 2.0 Hz, 1H), 7.86 (d, J = 8.6 Hz, 1H), 8.01 (dd, J = 1.7, 0.7 Hz, 1H),
1
3
8
.17–8.19 (m, 3H), 8.81 (s, 1H); C NMR (100 MHz, CDCl
3
) δ 31.9, 32.1, 34.9, 35.1, 109.1, 111.6,
1
12.8, 113.4, 114.2, 116.4, 117.2, 119.2, 122.2, 122.7, 123.5, 123.9, 124.3, 125.6, 126.5, 134.1, 139.9,
+
1
5
43.1, 147.16 153.0, 153.2, 162.0, 162.3; HRMS (APCI) m/z (M+H) calcd for C41
H
41
N
O
2 2
:
93.3163, found: 593.3166.
2-(tert-Butyl)-10-(10H-phenoxazin-10-yl)bis(benzofuro)[2,3-b:3',2'-e]pyridine (4bd).
Purified by column chromatography (eluent nꢀhex/AcOEt 20:1) on silica gel followed by GPC
1
(CHCl
3
). 121.1 mg, 49%, white solid; m.p. 163.1–165.2 °C; H NMR (400 MHz, CDCl
3
): 1.45 (s,
9
H), 5.96 (dd, J = 8.0, 1.5 Hz, 2H), 6.60 (ddd, J = 7.4, 7.4, 1.6 Hz, 2H), 6.68 (ddd, J = 7.4, 7.4, 1.6
Hz, 2H), 6.74 (dd, J = 7.8, 1.6 Hz, 2H), 7.49 (dd, J = 8.6, 2.1 Hz, 1H), 7.60–7.61 (m, 2H), 7.89 (d, J
13
=
8.6 Hz, 1H), 8.01–8.02 (m, 2H), 8.79 (s, 1H); C NMR (100 MHz, CDCl
3
) δ 31.9, 35.1, 111.7,
1
12.7, 113.4, 114.4, 114.9, 115.6, 117.2, 121.6, 122.1, 122.8, 123.3, 123.4, 125.6, 125.7, 130.1, 134.7,
+
25 2 3
143.8, 144.0, 147.2, 153.1, 153.9, 161.9, 162.3; HRMS (APCI) m/z (M+H) calcd for C33H N O :
4
97.1860, found: 497.1851.
2-(tert-Butyl)-10-(10H-phenothiazin-10-yl)bis(benzofuro)[2,3-b:3',2'-e]pyridine (4be).
Purified by column chromatography (eluent nꢀhex/AcOEt 20:1) on silica gel followed by GPC
1
(CHCl
3
). 67.0 mg, 17%, green solid; m.p. >300 °C; H NMR (400 MHz, CDCl
3
) δ 1.45 (s, 9H),
6
.23–6.25 (m, 2H), 6.83–6.87 (m, 4H), 7.05–7.07 (m, 2H), 7.55 (dd, J = 8.6, 2.1 Hz, 1H), 7.60–7.61
13
(
3
m, 2H), 7.90 (d, J = 8.6 Hz, 1H), 8.01–8.07 (m, 2H), 8.79 (s, 1H); C NMR (100 MHz, CDCl ) δ
31.3, 35.1, 111.6, 112.7, 114.3, 114.4, 116.0, 117.2, 120.1, 122.1, 122.7, 122.8, 123.5, 125.3, 125.7,
+
1
26.9, 127.0, 130.5, 136.5, 144.6, 147.1, 153.0, 153.8, 161.9, 162.2; HRMS (APCI) m/z (M+H)
2
6
ACS Paragon Plus Environment